🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Egypt / NCT07260279
Starting soon Not applicable

Effect of an Educational Session for Abortive Women on Maternity Nurses' Practices

NCT07260279 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-02-01
Last updated
2026-03-03

Condition(s) studied

AbortionPracticeMaternity

Investigational drug(s) / intervention(s)

Educational Training Program on Abortion Care

Educational Training Program on Abortion Care: The educational intervention consisted of structured training sessions for maternity nurses focusing on abortion care practices, including lectures, demonstrations, and discussions to improve skills and practices

Study summary

The goal of this study is to evaluate the effect of structured educational sessions for abortive women on the practices of maternity nurses.

The study aims to enhance nurses' clinical skills and patient care related to abortion management.

Participants will:

Attend educational sessions designed to improve nursing practices

Participate in activities and discussions led by experienced instructors

Be observed before and after the sessions to assess changes in clinical practices

The study will compare nursing practices before and after the intervention to determine the overall impact of the educational sessions on professional performance and patient care quality.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: Registered maternity nurses working in obstetrics or gynecology departments. Having at least one year of clinical experience in maternity or reproductive health units. Willing to participate and provide informed consent. Able to read and understand the educational materials provided. Present at the workplace during the study and follow-up periods. Not previously involved in similar abortion care training programs. Exclusion Criteria: Nurses on maternity or annual leave during the study period. Administrative or non-clinical nursing staff. Nurses with less than one year of professional experience. Refusal to participate or withdrawal at any stage of the study. Attendance of any concurrent external training on abortion or reproductive health during the study. Incomplete participation in the educational intervention sessions.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mansoura University Hospital Al Mansurah Dakahlia Governorate

More Mansoura University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07260279 on ClinicalTrials.gov ↗ ← All trials in Egypt